Search Results - "de Haan, J G"

Refine Results
  1. 1

    Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia by Berghuis, B., de Haan, G.-J., van den Broek, M. P. H., Sander, J. W., Lindhout, D., Koeleman, B. P. C.

    Published in European journal of neurology (01-09-2016)
    “…The use of carbamazepine (CBZ) and oxcarbazepine (OXC) as first‐line antiepileptic drugs in the treatment of focal epilepsy is limited by hyponatremia, a known…”
    Get full text
    Journal Article
  2. 2

    Electro‐clinical criteria and surgical outcome: Is there a difference between mesial and lesional temporal lobe epilepsy? by Wassenaar, M., Leijten, F. S. S., Haan, G.‐J., Uijl, S. G., Sander, J. W.

    Published in Acta neurologica Scandinavica (01-12-2017)
    “…Objectives Mesial temporal lobe epilepsy syndrome (MTLE) with specific electrophysiological and clinical characteristics and hippocampal sclerosis (HS) on MRI…”
    Get full text
    Journal Article
  3. 3

    Gestation-induced changes in lamotrigine pharmacokinetics: A monotherapy study by DE HAAN, G-J, EDELBROEK, P, SEGERS, J, ENGELSMAN, M, LINDHOUT, D, DEVILE-NOTSCHAELE, M, AUGUSTIJN, P

    Published in Neurology (10-08-2004)
    “…The authors describe 12 pregnancies in women with epilepsy using lamotrigine (LTG) monotherapy. A seizure increase in nine pregnancies was probably related to…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers by Knoester, P. D., Jonker, D. M., Van Der Hoeven, R. T. M., Vermeij, T. A. C., Edelbroek, P. M., Brekelmans, G. J., De Haan, G. J.

    Published in British journal of clinical pharmacology (01-05-2002)
    “…Aims  To investigate the pharmacokinetic and pharmacodynamic profile of midazolam administered as a concentrated intranasal spray, compared with intravenous…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Selection criteria for the clinical use of the newer antiepileptic drugs by DECKERS, Charles L. P, KNOESTER, P. D, DE HAAN, G. J, KEYSER, A, RENIER, W. O, HEKSTER, Y. A

    Published in CNS drugs (2003)
    “…In recent years, several new antiepileptic drugs (AEDs) have been licensed: felbamate, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, tiagabine,…”
    Get full text
    Journal Article
  7. 7

    Hyperactive behavior in a family with autosomal dominant lateral temporal lobe epilepsy caused by a mutation in the LGI1 /epitempin gene by Berghuis, B, Brilstra, E.H, Lindhout, D, Baulac, S, de Haan, G.J, van Kempen, M

    Published in Epilepsy & behavior (01-07-2013)
    “…Abstract Autosomal dominant lateral temporal lobe epilepsy (ADLTE) is characterized by focal seizures with auditory features or aphasia. Mutations in the…”
    Get full text
    Journal Article
  8. 8

    Influence of an Evacuation in February 1995 in The Netherlands on the Seizure Frequency in Patients with Epilepsy: A Controlled Study by Swinkels, W. A. M., Engelsman, M., Kasteleijn‐Nolst Trenité, D. G. A., Baal, M. G., Haan, G. J., Oosting, J.

    Published in Epilepsia (Copenhagen) (01-11-1998)
    “…Purpose: Stress is often noted by patients to be a precipitating factor in causing seizures. No precise data are, however, available. In 1995 for 250,000…”
    Get full text
    Journal Article
  9. 9

    Lacosamide monotherapy in clinical practice: A retrospective chart review by Villanueva, V., Giráldez, B. G., Toledo, M., De Haan, G. J., Cumbo, E., Gambardella, A., De Backer, M., Joeres, L., Brunnert, M., Dedeken, P., Serratosa, J.

    Published in Acta neurologica Scandinavica (01-09-2018)
    “…Objective To assess effectiveness and tolerability of first‐line and conversion to lacosamide monotherapy for focal seizures. Materials and Methods…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Major complications and risk factors associated with surgical correction of congenital medial patellar luxation in 124 dogs by Cashmore, R G, Havlicek, M, Perkins, N R, James, D R, Fearnside, S M, Marchevsky, A M, Black, A P

    “…Dogs treated for congenital medial patellar luxation were reviewed for the purpose of determining the incidence of postoperative major complications requiring…”
    Get more information
    Journal Article
  12. 12

    Current approaches to the use of generic antiepileptic drugs by Krämer, G, Biraben, A, Carreno, M, Guekht, A, de Haan, G.J, Jędrzejczak, J, Josephs, D, van Rijckevorsel, K, Zaccara, G

    Published in Epilepsy & behavior (01-08-2007)
    “…Abstract Generic substitution is encouraged as a cost containment strategy for the management of health care resources. However, in epilepsy, the consequences…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Hepatic, intestinal and renal transport of 1-naphthol-β-D-glucuronide in mutant rats with hereditary-conjugated hyperbilirubinemia by DE VRIES, M. H, REDEGELD, F. A. M, KOSTER, A. S, NOORDHOEK, J, DE HAAN, J. G, OUDE ELFERINK, R. P. J, JANSEN, P. L. M

    “…Recently, a mutant rat strain was described with a genetic defect for the biliary excretion of organic anions (TR-rats). To determine the possible…”
    Get full text
    Journal Article
  15. 15

    Amino acid release from cerebral cortex in experimental acute liver failure, studied by in vivo cerebral cortex microdialysis by Bosman, D K, Deutz, N E, Maas, M A, van Eijk, H M, Smit, J J, de Haan, J G, Chamuleau, R A

    Published in Journal of neurochemistry (01-08-1992)
    “…Both increased gamma-aminobutyric acid (GABA)-ergic and decreased glutamatergic neurotransmission have been suggested relative to the pathophysiology of…”
    Get more information
    Journal Article
  16. 16

    Fundamental limits for the recycling of end-of-life vehicles by Reuter, M.A., van Schaik, A., Ignatenko, O., de Haan, G.J.

    Published in Minerals engineering (2006)
    “…This paper explores the limits of recycling on a fundamental basis. This fundamental basis suggests that the high recycling quotas for end-of-life vehicles…”
    Get full text
    Journal Article
  17. 17

    The use of in vivo proton NMR to study the effects of hyperammonemia in the rat cerebral cortex by de Graaf, A A, Deutz, N E, Bosman, D K, Chamuleau, R A, de Haan, J G, Bovee, W M

    Published in NMR in biomedicine (01-02-1991)
    “…Using in vivo 1H NMR spectroscopy (1H MRS) and biochemical analysis, the effects of hyperammonemia on cerebral function were studied in three rat models: acute…”
    Get more information
    Journal Article
  18. 18

    A Novel Splicing Mutation in KCNQ2 in a Multigenerational Family with BFNC Followed for 25 Years by De Haan, Gerrit‐Jan, Pinto, Dalila, Carton, Dietbrandt, Bader, Adri, Witte, Jorien, Peters, Edith, Van Erp, Gerard, Vandereyken, Willem, Boezeman, Eduard, Wapenaar, Martin C., Boon, Paul, Halley, Dicky, Koeleman, Bobby P. C., Lindhout, Dick

    Published in Epilepsia (Copenhagen) (01-05-2006)
    “…Purpose: A large multigenerational family with benign familial neonatal convulsions (BFNC) was revisited to identify the disease‐causing mutation and to assess…”
    Get full text
    Journal Article
  19. 19

    Inhibition of nitric oxide synthase by nasal decongestants by Westerveld, GJ, Voss, HP, van der Hee, RM, de Haan-Koelewijn, GJ, den Hartog, GJ, Scheeren, RA, Bast, A

    Published in The European respiratory journal (01-09-2000)
    “…The nasal decongestants oxymetazoline and xylometazoline are frequently used in the topical treatment of rhinitis and sinusitis. As nitric oxide (NO) is…”
    Get full text
    Journal Article
  20. 20

    Inside Front Cover by Villanueva, V, Giráldez, B G, Toledo, M, De Haan, G J, Cumbo, E, Gambardella, A, De Backer, M, Joeres, L, Brunnert, M, Dedeken, P, Serratosa, J

    Published in Acta neurologica Scandinavica (01-09-2018)
    “…The cover image, by Vicente Villanueva et al., is based on the Paper Lacosamide monotherapy in clinical practice: A retrospective chart review, DOI:…”
    Get full text
    Journal Article